Skip to content

Amphastar Pharmaceuticals, Inc.

AMPH

CIK 0001297184

← back to feed
Revenue (TTM)
$707.95M
−1.7% YoY Q1 May 2026
Net Income (TTM)
$80.09M
−38.5% YoY Q1 May 2026
EPS Diluted (TTM)
$1.66
−33.7% YoY Q1 May 2026
Gross Margin
48.1%
Q1 May 2026
Operating Margin
16.7%
Q1 May 2026
Net Margin
11.3%
Q1 May 2026
Free Cash Flow (TTM)
$140.12M
Q1 May 2026
Cash
$170.94M
Q1 May 2026
Total Debt
$619.71M
Q1 May 2026
Shares Outstanding
44.09M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings